feangli Red Light Therapy Knee Massager for Knee Pain Relief, FSA&HSA
Light Therapy - 产品分析报告
  • Benchmark ASIN
    B0GVST1FR1
  • Marketplace
    US
  • Category ID
    13053141
  • Analyzed Products
  • Keyword
    home health products
  • Price Range
    -
  • Minimum Net Profit Margin
    10.00%
  • MOQ
    100
  • Est. Purchasing Cost
    No price data
  • Data Date
    2026-07-28
  • Your Budget (for new listing) (CNY)
    ¥500,000.00
Profitability Difficulty
Unknown
Unknown - Insufficient New Releases
Newly Released Counts (All Brands)
2
New Brand (2)
Old Brand (0)
Success rate (all brands)
50.00%
New Brand (50.00%)
Old Brand (0%)
Most products net profit margin range
N/A
Listing

Report summary from Keble AI Agent: Listing

结论很直接:这个市场不值得进入。 目前只有 1 个新品牌 feangli,2 个新上架里 1 个盈利、1 个亏损,表面成功率 50%,但样本太少,而且没有看到 30~100+ 新品牌涌入的扩张信号,也没有形成可复制的低门槛路径;更关键的是,能跑出来的成功款是靠功能差异化和较高前期投入撑起来的,不是适合小商家轻松复制的赛道。

证据很清楚:市场并没有变成稳定增长机会,而是典型的高门槛、强差异化打法。 盈利款 B0GVST1FR1 价格 53.13 美元,毛利率 38.22%,月销约 200 件、月收入约 10,626 美元,成功原因是“三波长红光/近红外 + 5档振动 + 定时关机”的组合差异;而亏损款 B0GHRFLDTQ 几乎没有销量,失败原因是同质化太强、目标人群重叠高。品牌层面,feangli 作为新品牌只有这 2 个样本,盈利/亏损各 1 个,没有形成强势品牌壁垒,但已经能看出进入门槛主要在研发和产品创新,不在低价铺货。用户预算 50 万人民币大致能覆盖单个 ASIN 的前期入场,但这只够“试一条单品活路”,不够支撑长期研发、品牌和认证投入;对小商家来说,真实成功案例只有 B0GVST1FR1 这一条,且不是低预算模型。

最终判断:大品牌可以做,但必须带着明确功能升级和更强预算;小商家不建议进场。 这个类目没有出现大规模新品牌涌入,也没有明显的价格战,但现有成功路径已经偏向高投入、高差异化;如果要硬做,只能跟着 feangli 这类“功能更新型”产品走,而不是复制普通护膝式红光款。

Recommended Products Features Direction
B0GVST1FR1
Why do customers choose it?
  • 护膝式可穿戴包裹结构,带屏显与发光面板的理疗外观
  • 三波长红光/近红外 + 5档振动 + 定时自动关机,功能组合更强
  • 需要膝盖理疗、同时希望便携使用的中老年关节护理人群
  • Sales
    Avg. price: $53.13|Latest price: $54.99|Approx. recent monthly revenue: $10,626.00 (200 pcs)|Net profit margin: 38.22%
    B0GHRFLDTQ
    Why do customers choose it?
  • 黑色主体配红光显示,外观与同类红光护膝高度接近
  • 护膝式包裹结构,属于市面常见的红光+热敷/震动形态
  • 仅在常规护膝基础上叠加红光理疗,功能组合不够差异化
  • 主要面向膝关节疼痛、理疗恢复人群,但目标人群与竞品重叠很高
  • Sales
    Avg. price: -|Latest price: -|Approx. recent monthly revenue: - (- pcs)|-

    These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.

    New Brands
    VS
    Old Brands
    1 new brands0 old brands
    1 brands have new listings0 brands have new listings
    2 new listings0 new listings
    1 succeeded
    0 succeeded
    1 failed
    0 failed

    Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.

    New Brands

      How much did others invest?

      Collapse
    • #Budget Requirement

      Listing

      结论很明确:这个市场不值得进入。 用户预算50万人民币看起来够覆盖单个ASIN的前期入场,但市场里新品牌新上架成功率只有50%,样本里一半新品牌新品直接失败,而且成功/失败各只有1个样本,说明这里不是稳定机会,而是靠少数产品勉强跑出来的市场;更关键的是,当前数据没有看到能支撑中小卖家复制的低门槛成功路径,反而更像是需要强功能差异化和持续投放的高成本赛道。

      Early sourcing + logistics + marketing budget (USD)
      N/A
      Explains the budget

      With all these investments, who has profitable new releases

      How many new listings are released by old brands?
      0.00%
      New listing success rate (new brands):
      50.00%
      Which new brands have these successful new listings?
      Other major expenses
      R&D
      Alternatives
      1. 常规护膝/髌骨带:价格更低、穿戴更简单,适合只想要日常支撑和轻度疼痛缓解的人群。
      2. 一次性或可重复使用热敷贴:无需充电、无需学习操作,适合临时缓解膝部僵硬和酸痛,使用门槛更低。
      3. 冰敷袋/冷热敷凝胶包:成本低、通用性强,适合运动后肿胀或急性不适场景,比专用理疗设备更容易获得。
      4. 弹力绷带/压力护套:便宜、轻便、随时可用,能提供基础压迫与稳定感,适合作为低预算替代。
      5. 家用泡沫轴/按摩球:单次投入低,可用于腿部周边肌群放松,帮助间接减轻膝周负担。
      6. 基础电热护膝/USB加热护膝:通常比红光+振动多功能产品更便宜,功能更直观,适合只需要热敷的人。
      7. 在线/APP引导的膝关节康复动作方案:几乎零硬件成本,适合不想买设备、希望先用动作管理疼痛和活动度的人。

      Alternative solutions may pose a risk to your investment in certain markets.

    • #Brands Investment Analysis

      Listing

      这个市场不值得进入:当前样本里只有 2 个新品牌新品,盈利/亏损各 1 个,表面看盈利率 50%,但没有任何“30~100+ 新品牌涌入”的扩张迹象,反而是新品牌刚进场就出现一正一负的分化,说明这个细分更像是靠单品打法和差异化吃饭,不是可复制的低门槛机会。 对大品牌来说可以做,但必须带着明显的功能创新和更强预算;对小商家来说,只有极少数真实成功案例,且要避开同质化护膝款。

      feangli
      New products with Highest revenueLeast investment in new productsMost investment in new products
      feangli Red Light Therapy Knee Massager for Knee Pain Relief, FSA&HSA
      Recent Monthly Revenue (USD):$10,626.00(200pcs/month)
      B0GVST1FR1 (4.4/5 (125 Reviews))Brand is a new entry in this market
      New ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable
    • #Differentiations

      Unique productsCommon products
      feangli Red Light Therapy Knee Massager for Knee Pain Relief, FSA&HSA
      Differentiation:
      1. Product features and designs are too common without differentiation
      B0GVST1FR1 (4.4/5 (125 Reviews))Brand is a new entry in this market
      New ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable
      feangli Red Light Therapy Knee Brace
      Differentiation:
      1. Product features and designs are too common without differentiation
      B0GHRFLDTQBrand is a new entry in this market
      New ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ
    • What net profit margin are others making?

      Collapse
    • #Net Profit Margins: All vs New

      Listing

      这不是一个值得进入的市场:新品牌只有1个、旧品牌为0,但新品牌新款只有50%成功率,且失败款B0GHRFLDTQ几乎没有销量,说明当前样本里“能卖”的只有靠差异化做起来的单品,而不是稳定、可复制的机会。 用户预算50万CNY看起来足够覆盖B0GVST1FR1这类单品的前期投入(早期投入约15,865.68美元,广告约3,568.19美元),但这更像“高投入换一条单品活路”,不是低成本可复制的入场窗口。

      Profitability difficulty
      Unknown - Insufficient New Releases

      All products distribution on different profit levels

      All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.

      x < -10.0%
      -10.0% <= x < 0.0%
      0.0% <= x < 10.0%
      10.0% <= x < 20.0%
      20.0% <= x < 30.0%
      30.0% <= x < 40.0%
      x >= 40.0%
      other

      New products distribution on different profit levels

      This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'

      x < -10.0%
      -10.0% <= x < 0.0%
      0.0% <= x < 10.0%
      10.0% <= x < 20.0%
      20.0% <= x < 30.0%
      30.0% <= x < 40.0%
      x >= 40.0%
      other
    • #Top Products by Net Profit Margin

      Top 20 Profitable Products

      Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.

      B0GVST1FR1
      B0GVST1FR1
      feangli
      2026-05-30
      Yes
      $53.13
      200pcs
      $10626.0
      38.22%
      $4061.26

      Top 20 Profitable New Products

      Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.

      B0GVST1FR1
      B0GVST1FR1
      feangli
      2026-05-30
      Yes
      $53.13
      200pcs
      $10626.0
      38.22%
      $4061.26
    • Is this a good time to enter the market?

      Collapse
    • #New Product Success Rates

      Listing

      这个市场不值得进入。 目前样本里新品牌只有 feangli 一家,且新上架产品成败各一半(50%/50%);更关键的是,真正能成立的成功案例只有 B0GVST1FR1 这一条,而它依靠的是 38.2% 利润率、约 15,865.68 美元的早期投入和明显的功能差异化,不是低预算可复制的普通打法。

      New products success rate.

      What is the ratio of profitable products

      Profitable (Unidentifiable released date)
      Profitable (Old product)
      Profitable (New product)
      Profitable (New product on old listing)
      New products but non profitable

      Profitable new products divide by brands

      What is the ratio of different brands owning all profitable new products

      feangli

      Nonprofitable new products divide by brands

      What is the ratio of different brands owning all nonprofitable new products

      feangli
    • #Success Rate by Entry Time

      Listing

      这个市场目前不适合进入,且不该投入。 近几年几乎没有持续的新品牌扩张信号,真正能跑出来的只有 feangli 的单一样本:B0GVST1FR1 勉强盈利,B0GHRFLDTQ 直接亏损,说明这个类目不是稳定放量,而是极少数产品偶发成单,整体可复制性很差。

      How many products released each year

      Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing

      How many products released each month

      Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing

    • #Net Profit Margins by Entry Time

      Different profit ratios of products released in year

      Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.

      Time/Profit%x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other
      202200000000
      202300000000
      202400000000
      202500000000
      202600000101
      ≥ 10% Profitable
      < 10% Unprofitable
      Unidentifiable

      Different profit ratios of products released in month

      Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.

      Time/Profit%x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other
      2025/700000000
      2025/800000000
      2025/900000000
      2025/1000000000
      2025/1100000000
      2025/1200000000
      2026/100000001
      2026/200000000
      2026/300000000
      2026/400000000
      2026/500000100
      2026/600000000
      ≥ 10% Profitable
      < 10% Unprofitable
      Unidentifiable
    • What factors contribute to success or failure?

      Collapse
    • #Case Study

      Success Cases
      feangli Red Light Therapy Knee Massager for Knee Pain Relief, FSA&HSA
      Price (USD)
      $53.13
      Released Type
      New Release (2026-05-30)
      Brand is a new entry in this market
      Size and Weight
      21.3 x 18.0 x 7.8 cm, 499.00g

      Profitable Factors

      Based on old ASINDistinct functions and features

      Design & Appearance

      护膝式可穿戴包裹结构,带屏显与发光面板的理疗外观

      Key Buying Motive

      三波长红光/近红外 + 5档振动 + 定时自动关机,功能组合更强

      Target Customers

      需要膝盖理疗、同时希望便携使用的中老年关节护理人群

      Early Investment

      Investment

      Monthly Revenue (Recent) (USD)
      $10,626.00
      200 sold in the past 30 days · as of 2026年7月

      Net Profit Margin

      Sea Freight
      36.67% / 38.22%
      Peak / Non Peak
      Rail Freight
      - / -
      Peak / Non Peak
      Air Freight
      32.09% / 33.64%
      Peak / Non Peak

      Sales & BSR Performance

    What is Keble?

    Keble is an e-commerce AI Agent that helps sellers solve daily e-commerce issues. This report is generated by Keble AI.

    Analyze Product Opportunity with Keble
    1. One report to tell you whether to enter the market or not, significantly reducing inventory risk.
    Keble AI Agent